bimekizumab – Patient Worthy

rawpixel / Pixabay

Bimekizumab Shows Promise for Ankylosing Spondylitis, Study Shows

Post author:Jessica Lynn
Post published:December 31, 2021
Post category:Ankylosing Spondylitis Uveitis

The Phase 3 BE MOBILE 2 clinical trial sought to evaluate the safety, efficacy, and tolerability of bimekizumab for adult patients with ankylosing spondylitis (AS), an inflammatory disease affecting…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More